PYCR1 and pancreatic neoplasm: Moreover, pancreatic cancer patients with low PRODH, P4HA and PYCR1 expression had longer survival times than cancer patients with higher expression; in contrast, patients with low PRODH2 expression had shorter survival times than those with high PRODH2 expression (Supplementary Fig. 4).